Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Biliary tract cancer

  • You have access
    Preoperative Neutrophil-to-lymphocyte Ratio Predicts Tumor-infiltrating CD8+ T Cells in Biliary Tract Cancer
    RYOTA TANAKA, KENJIRO KIMURA, SHINPEI EGUCHI, JUN TAUCHI, MASATUNE SHIBUTANI, HIROJI SHINKAWA, GO OHIRA, SADAAKI YAMAZOE, SHOGO TANAKA, RYOSUKE AMANO, HIROAKI TANAKA, MASAKAZU YASHIRO, SHOJI KUBO and MASAICHI OHIRA
    Anticancer Research May 2020, 40 (5) 2881-2887; DOI: https://doi.org/10.21873/anticanres.14264
  • You have access
    Aberrant Methylation of Tumor Suppressive miRNAs in Bile from Patients With Pancreaticobiliary Diseases
    KOUSHIRO OHTSUBO, KUNIO MIYAKE, SACHIKO ARAI, KOJI FUKUDA, NAOHIRO YANAGIMURA, CHIAKI SUZUKI, SAKIKO OTANI, YUTA ADACHI, AZUSA TANIMOTO, AKIHIRO NISHIYAMA, KANAME YAMASHITA, SHINJI TAKEUCHI, KENJI NOTOHARA, KENICHI YOSHIMURA and SEIJI YANO
    Anticancer Research October 2019, 39 (10) 5449-5459; DOI: https://doi.org/10.21873/anticanres.13738
  • You have access
    The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer
    NAOHIRO OKANO, AKIYOSHI KASUGA, KIRIO KAWAI, YOSHIYA YAMAUCHI, TAKAAKI KOBAYASHI, DAISUKE NARUGE, FUMIO NAGASHIMA and JUNJI FURUSE
    Anticancer Research March 2018, 38 (3) 1755-1761;
  • You have access
    Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 Cases
    NAOHIRO OKANO, AKIYOSHI KASUGA, KIRIO KAWAI, TAKAAKI KOBAYASHI, DAISUKE NARUGE, FUMIO NAGASHIMA and JUNJI FURUSE
    Anticancer Research July 2017, 37 (7) 3711-3715;
  • You have access
    Surgical Resection for Pulmonary Metastasis from Pancreatic and Biliary Tract Cancer
    TETSUZO TAGAWA, KENSAKU ITO, KENGO FUKUZAWA, TATSURO OKAMOTO, ATSURO YOSHIMURA, TAKAHIDE KAWASAKI, TAKASHI MASUDA, KENTARO IWAKI, TAKAHIRO TERASHI, MASAHIRO OKAMOTO, AKIO SHIROMIZU, AKIRA MOTOHIRO and YOSHIHIKO MAEHARA
    Anticancer Research March 2017, 37 (3) 1413-1416;
  • You have access
    Multicenter Phase II Clinical Trial of Genexol-PMĀ® with Gemcitabine in Advanced Biliary Tract Cancer
    JIN YOUNG KIM, YOUNG ROK DO, HONG SUK SONG, YOON YOUNG CHO, HUN MO RYOO, SUNG HWA BAE, JONG GWANG KIM, YEE SOO CHAE, BYUNG WOOG KANG, JIN HO BAEK, MIN KYOUNG KIM, KYUNG HEE LEE and KEONUK PARK
    Anticancer Research March 2017, 37 (3) 1467-1473;
  • You have access
    Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies
    ILARIA MARINELLI, ALESSANDRA GUIDO, LORENZO FUCCIO, ANDREA FARIOLI, VALERIA PANNI, LUCIA GIACCHERINI, ALESSANDRA ARCELLI, GIORGIO ERCOLANI, GIOVANNI BRANDI, SILVIA CAMMELLI, ANDREA GALUPPI, GABRIELLA MACCHIA, REZARTA FRAKULLI, GIAN C. MATTIUCCI, FRANCESCO CELLINI, MILLY BUWENGE, MATTEO RENZULLI, FRANCESCO DEODATO, SAVINO CILLA, VINCENZO VALENTINI, VINCENZO TOMBOLINI, RITA GOLFIERI and ALESSIO G. MORGANTI
    Anticancer Research March 2017, 37 (3) 955-961;
  • You have access
    A Multicenter Phase II Study of Gemcitabine plus S-1 Chemotherapy for Advanced Biliary Tract Cancer
    SHIHO ARIMA, KYOKO SHIMIZU, TOMOYOSHI OKAMOTO, MASAO TOKI, YUTAKA SUZUKI, NAOHIRO OKANO, DAISUKE NARUGE, KIRIO KAWAI, TAKAAKI KOBAYASHI, AKIYOSHI KASUGA, HIROSHI KITAMURA, ATUKO TAKASU, FUMIO NAGASHIMA, MASANORI SUGIYAMA and JUNJI FURUSE
    Anticancer Research February 2017, 37 (2) 909-914;
  • You have access
    No Survival Benefit from the Inhibition of Renin–Angiotensin System in Biliary Tract Cancer
    YOUSUKE NAKAI, HIROYUKI ISAYAMA, TAKASHI SASAKI, NAMINATSU TAKAHARA, KEI SAITO, TSUYOSHI TAKEDA, GYOTANE UMEFUNE, TOMOTAKA SAITO, KAORU TAKAGI, TAKEO WATANABE, TSUYOSHI HAMADA, RIE UCHINO, SUGURU MIZUNO, KEISUKE YAMAMOTO, HIROFUMI KOGURE, SABURO MATSUBARA, NATSUYO YAMAMOTO, HIDEAKI IJICHI, KEISUKE TATEISHI, MINORU TADA and KAZUHIKO KOIKE
    Anticancer Research September 2016, 36 (9) 4965-4970;
  • You have access
    Assessment of Surgical Outcome After Pancreatic Resection in Extremely Elderly Patients
    YOSHIHIRO SHIRAI, HIROAKI SHIBA, TAKASHI HORIUCHI, NOBUHIRO SAITO, KENEI FURUKAWA, TARO SAKAMOTO, TAKESHI GOCHO, YUICHI ISHIDA and KATSUHIKO YANAGA
    Anticancer Research April 2016, 36 (4) 2011-2017;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire